Company intelligence / Profile preview

Jichuan Pharmaceutical

Taizhou, Jiangsu, Chinamarketscreener.com ↗

Ownership: Private
Development stage: Other

Overview

Jichuan Pharmaceutical has a broad portfolio of over one hundred products, including both Western medicines and traditional Chinese medicines. Its flagship product Jianwei Xiaoshi oral liquid has demonstrated efficacy in pediatric dyspepsia through modulation of gut microbiota and pancreatic secretion pathways. The company’s revenues have grown steadily, with strong profitability reported for recent years. Many of its products are included in China’s National Medical Insurance Catalog.

Therapeutic areas: GastroenterologyPulmonologyCardiovascularOther
Modalities: Small moleculeHerbal medicine (Traditional Chinese Medicine)Biologic
Industry: Biotech

Drug pipeline

4 assets

Chuanbei Qing

Unknown

3 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Jichuan Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jichuan Pharmaceutical.

Explore the full profile